The combination of strong financial performance, strategic growth initiatives through hospital alliances, and capital return through dividends and buybacks suggests confidence in future growth. The CFO transition is orderly with an experienced interim replacement, minimizing leadership risk.
Price Chart
Executive Summary
U.S. Physical Therapy reported strong 2025 financial results with 16.2% growth in Adjusted EBITDA to $95.0 million and a 30.3% increase in adjusted operating income. The company announced a CFO transition, raised its quarterly dividend, repurchased $5.6 million in shares, and secured strategic hospital alliances expected to contribute $7.3 million in annual EBITDA.
Key Facts
- Adjusted EBITDA increased 16.2% year-over-year to $95.0 million for 2025
- Net revenue from physical therapy operations increased 13.0% to $173.8 million in Q4 2025
- CFO Carey Hendrickson is resigning, with Jason Curtis assuming interim CFO role
- Quarterly dividend increased from $0.45 to $0.46 per share
- Company repurchased $5.6 million in shares during Q4 2025
- Strategic hospital alliances expected to contribute $7.3 million in annual EBITDA
- 2026 Adjusted EBITDA guidance of $102.0-$106.0 million represents 7.4%-11.6% growth
- Physical therapy gross profit increased 25.3% to $35.2 million in Q4 2025
Financial Impact
Adjusted EBITDA increased $13.2 million to $95.0 million for 2025, with 2026 guidance of $102.0-$106.0 million. Strategic alliances will contribute $7.3 million in annual EBITDA.
Risk Factors
- CFO transition could create temporary leadership uncertainty
- Guidance incorporates only 'modest contribution' from new alliances, suggesting ramp-up risk
- Adjusted EBITDA growth in Q4 2025 was 13.5%, below the full-year 16.2% growth rate
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-006882 |
| Document: ef20066590_8k.htm | 0001140361-26-006882 |
| Document: 0001140361-26-006882-index-headers.html | 0001140361-26-006882 |
| Document: 0001140361-26-006882-index.html | 0001140361-26-006882 |
| Document: 0001140361-26-006882.txt | 0001140361-26-006882 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | SC 13G | $85.44 $87.02 | ▲ +1.85% | ▲ +3.00% | $87.34 (+2.22%) |
Aug 10, 2026 11w ago | 8-K | $81.67 $78.21 | ▼ −4.24% | ▼ −3.83% | $87.34 (+6.94%) |
May 6, 2026 24w ago | 8-K | $59.00 $60.14 | ▼ −1.93% | ▼ −0.43% | $87.34 (−48.03%) |
Apr 15, 2026 27w ago | 8-K | $78.18 $74.76 | ▼ −4.37% | ▼ −5.36% | $87.34 (+11.72%) |
Feb 26, 2026 34w ago | 8-K | $78.87 $82.14 | ▲ +4.15% | ▲ +5.27% | $87.34 (+10.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers